None listed
Conditions
Brief summary
Seasonal upper respiratory tract infections are nearly unavoidable, contributing to school absenteeism, employee absenteeism, and reduced quality of life. To our knowledge, all-natural, child-appropriate, non-pharmaceutical, scientifically supported symptom relief is rare. Therefore, this study aims to assess if BerriQi - a natural whole fruit-based product from Boysenberry and apple supports immune and lung health in primary school-age kids with respiratory infections. Validated illness-specific quality of life questionnaire (WURSS-K) will be used to assess the severity and duration of respiratory symptoms for 14 days in children missing school due to upper respiratory tract infection.
Interventions
BerriQi is a freeze-dried powder from Boysenberry and apple. Custom chewable tablets are made each containing 500 mg of BerriQi per chewable tablet. Additional ingredients include 500 mg xylitol and 25 mg of magnesium stearate.
Each participant will be instructed to consume 2 chewable tablets ( 1000 mg BerriQi) daily for 2 weeks. Participants will self-report on the daily questionnaire if they took BerriQi that day, which will be used as an indicator of adherence.
Sponsors
Anagenix
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
All
Age
5 Years to 13 Years
Healthy volunteers
No
Inclusion criteria
Participants and their family are willing and able to give informed consent for participation in the trial. 5-13 years of age. Willing to comply with the study protocol . Have upper respiratory infection symptoms triggering a school absence.
Exclusion criteria
Allergic to berries Not willing to provide informed consent
Outcome results
None listed